Patent ID: 6576660
Filing Date: 2003-06-10
Classification: A61K,A61P,C07C,C07D

Abstract:
A process of inhibiting 5&agr;-reductase activity comprising the step of exposing 5&agr;-reductase to an effective inhibiting amount of a compound selected from the group consisting of Myricetin, Quercitin, Baicalein, Fisetin, Kaempferol, Anthrarobin, Bromopyrogallol Red, Gossypol, Pyrogallol Red, Nordihydrogaiaretic Acid, Caffeic Acid Phenethyl Ester, Octyl Gallate, Purpurogallin, Hydroxydopamine, Dodecylgallate, Pyrocatechol Violet, Pyrogallol, Hematoxylin, Curcumin, Tetrahydrocurcumin, Purpurin, Alizarin, Menadione, Coenzyme q, 2,5-dichloroindophenol, Anthrarufin, Lapachol, Crocetin, 5,8,11,14-Ecostetraynoic Acid, Nordihydroguaiaretic Acid, Alizarin Red S, Isopropyl Gallate, and Gallic Acid.